The Mycobacterial Cohort Study (MyCoS) stores biomaterial (plasma, serum, PBMC’s, PAXgene and DNA) from patients being treated at Radboudumc for a mycobacterial infection, together with data about the patient's disease course. Through the MyCoS biobank a platform will be created to answer diagnostic, pathophysiological and prognostic questions about mycobacterial infections.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl)19 July 2022
The Ministry of Health, Welfare and Sport (VWS) is currently preparing a Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl) which will serve in the future as a specific legal framework for the (further) use of body tissue for medical scientific research.read more